Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study

Siegel, 2022, Cancer statistics, 2022, CA Cancer J Clin, 72, 7, 10.3322/caac.21708 Motzer, 2022, Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology, J Natl Compr Canc Netw, 20, 71, 10.6004/jnccn.2022.0001 Stewart, 2014, Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines, J Clin Oncol, 32, 4059, 10.1200/JCO.2014.56.5416 Choueiri, 2021, Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma, N Engl J Med, 385, 683, 10.1056/NEJMoa2106391 Ravaud, 2016, Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy, N Engl J Med, 375, 2246, 10.1056/NEJMoa1611406 Zhang, 2013, Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis, Lancet Oncol, 14, 1295, 10.1016/S1470-2045(13)70491-1 Sparano, 2015, Prospective validation of a 21-gene expression assay in breast cancer, N Engl J Med, 373, 2005, 10.1056/NEJMoa1510764 Leibovich, 2003, Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials, Cancer, 97, 1663, 10.1002/cncr.11234 Wei, 2019, Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study, Lancet Oncol, 20, 591, 10.1016/S1470-2045(18)30932-X Rini, 2015, A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies, Lancet Oncol, 16, 676, 10.1016/S1470-2045(15)70167-1 Skrede, 2020, Deep learning for prediction of colorectal cancer outcome: a discovery and validation study, Lancet, 395, 350, 10.1016/S0140-6736(19)32998-8 Ehteshami Bejnordi, 2017, Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer, JAMA, 318, 2199, 10.1001/jama.2017.14585 Amin, 2017, The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging, CA Cancer J Clin, 67, 93, 10.3322/caac.21388 Zhang, 2021, Uniform genomic data analysis in the NCI Genomic Data Commons, Nat Commun, 12 Schutz, 2013, Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study, Lancet Oncol, 14, 81, 10.1016/S1470-2045(12)70517-X Hakimi, 2016, Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma, Cancer, 122, 402, 10.1002/cncr.29765 Altman, 2012, Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration, BMC Med, 10, 51, 10.1186/1741-7015-10-51 Collins, 2015, Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement, Ann Intern Med, 162, 55, 10.7326/M14-0697 Heidari, 2016, Sex and gender equity in research: rationale for the SAGER reporting guideline and recommended use, Res Integr Peer Rev, 1, 2, 10.1186/s41073-016-0007-6 Liang, 2015, Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer, J Clin Oncol, 33, 861, 10.1200/JCO.2014.56.6661 Heagerty, 2000, Time-dependent ROC curves for censored survival data and a diagnostic marker, Biometrics, 56, 337, 10.1111/j.0006-341X.2000.00337.x Tang, 2018, Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study, Lancet Oncol, 19, 382, 10.1016/S1470-2045(18)30080-9 Bersanelli, 2021, Classification and personalized prognostic assessment on the basis of clinical and genomic features in myelodysplastic syndromes, J Clin Oncol, 39, 1223, 10.1200/JCO.20.01659 Albain, 2010, Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial, Lancet Oncol, 11, 55, 10.1016/S1470-2045(09)70314-6 Sparano, 2021, Development and validation of a tool integrating the 21-gene recurrence score and clinical–pathological features to individualize prognosis and prediction of chemotherapy benefit in early breast cancer, J Clin Oncol, 39, 557, 10.1200/JCO.20.03007 Courtiol, 2019, Deep learning-based classification of mesothelioma improves prediction of patient outcome, Nat Med, 25, 1519, 10.1038/s41591-019-0583-3 Kather, 2019, Predicting survival from colorectal cancer histology slides using deep learning: a retrospective multicenter study, PLoS Med, 16, 10.1371/journal.pmed.1002730